File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma

TitleInhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma
Authors
KeywordsAutologous transplantation
Natural killer cells
Lymphoma
Solid tumour
Issue Date2007
Citation
British Journal of Cancer, 2007, v. 97, n. 4, p. 539-542 How to Cite?
AbstractGenes that encode killer Ig-like receptors (KIRs) and their HLA class I ligands segregate independently; thus, some individuals may express an inhibitory KIR gene but not its cognate ligand. We hypothesised that these patients with KIR-HLA receptor-ligand mismatch have a low risk of relapse after an autologous haematopoietic stem cell transplantation (HCT). Sixteen consecutive patients with lymphoma or solid tumour were enrolled onto a prospective study. They received high-dose busulphan and melphalan followed by autologous CD133+ HCT. We found that 8 of the 16 patients experienced disease progression after autologous HCT, including 5 of the 6 patients (83%) with no inhibitory KIR-HLA mismatch and 3 of the 6 patients (50%) with 1 mismatched pair; none of the 4 (0%) patients with 2 mismatched pairs experienced disease progression. Survival analyses showed that inhibitory KIR-HLA mismatch was the only significant prognostic factor (P=0.01). The potential applicability of the receptor-ligand mismatch model to autologous HCTs and to patients with lymphoma or solid tumour is clinically significant because of the prevalence of the HCT procedure. © 2007 Cancer Research UK.
Persistent Identifierhttp://hdl.handle.net/10722/294423
ISSN
2023 Impact Factor: 6.4
2023 SCImago Journal Rankings: 3.000
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLeung, W.-
dc.contributor.authorHandgretinger, R.-
dc.contributor.authorIyengar, R.-
dc.contributor.authorTurner, V.-
dc.contributor.authorHolladay, M. S.-
dc.contributor.authorHale, G. A.-
dc.date.accessioned2020-12-03T08:22:42Z-
dc.date.available2020-12-03T08:22:42Z-
dc.date.issued2007-
dc.identifier.citationBritish Journal of Cancer, 2007, v. 97, n. 4, p. 539-542-
dc.identifier.issn0007-0920-
dc.identifier.urihttp://hdl.handle.net/10722/294423-
dc.description.abstractGenes that encode killer Ig-like receptors (KIRs) and their HLA class I ligands segregate independently; thus, some individuals may express an inhibitory KIR gene but not its cognate ligand. We hypothesised that these patients with KIR-HLA receptor-ligand mismatch have a low risk of relapse after an autologous haematopoietic stem cell transplantation (HCT). Sixteen consecutive patients with lymphoma or solid tumour were enrolled onto a prospective study. They received high-dose busulphan and melphalan followed by autologous CD133+ HCT. We found that 8 of the 16 patients experienced disease progression after autologous HCT, including 5 of the 6 patients (83%) with no inhibitory KIR-HLA mismatch and 3 of the 6 patients (50%) with 1 mismatched pair; none of the 4 (0%) patients with 2 mismatched pairs experienced disease progression. Survival analyses showed that inhibitory KIR-HLA mismatch was the only significant prognostic factor (P=0.01). The potential applicability of the receptor-ligand mismatch model to autologous HCTs and to patients with lymphoma or solid tumour is clinically significant because of the prevalence of the HCT procedure. © 2007 Cancer Research UK.-
dc.languageeng-
dc.relation.ispartofBritish Journal of Cancer-
dc.subjectAutologous transplantation-
dc.subjectNatural killer cells-
dc.subjectLymphoma-
dc.subjectSolid tumour-
dc.titleInhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma-
dc.typeArticle-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1038/sj.bjc.6603913-
dc.identifier.pmid17667923-
dc.identifier.pmcidPMC2360345-
dc.identifier.scopuseid_2-s2.0-34547899909-
dc.identifier.volume97-
dc.identifier.issue4-
dc.identifier.spage539-
dc.identifier.epage542-
dc.identifier.eissn1532-1827-
dc.identifier.isiWOS:000249122700012-
dc.identifier.issnl0007-0920-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats